Immunotherapy for Visceral Leishmaniasis: Ability of Factors Produced during Anti-leishmania Responses of Skin Test Positive Adults to Inhibit Peripheral Blood Mononuclear Cell Activities Associated with Visceral Leishmaniasis

Memorias do Instituto Oswaldo Cruz

Volumn 94, Issue 1, 1999, Pages 55-66

  Holaday, Bettie J ^a,b  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b NONE   (United States)

Author keywords

Antigens; CD8+ T suppressor (Ts); IL 12; Immunotherapy; Interleukin (IL) 10; Leishmaniasis

Indexed keywords

LEISHMANIA DONOVANI CHAGASI;

IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 10; INTERLEUKIN 12;

ADOLESCENT; ADULT; ANIMAL; ARTICLE; CLINICAL TRIAL; HUMAN; IMMUNOLOGY; IMMUNOTHERAPY; LEISHMANIA INFANTUM; MIDDLE AGED; MONONUCLEAR CELL; SECRETION; SKIN TEST; VISCERAL LEISHMANIASIS;

ADJUVANTS, IMMUNOLOGIC; ADOLESCENT; ADULT; ANIMALS; HUMANS; IMMUNOTHERAPY; INTERLEUKIN-10; INTERLEUKIN-12; LEISHMANIA INFANTUM; LEISHMANIASIS, VISCERAL; LEUKOCYTES, MONONUCLEAR; MIDDLE AGED; SKIN TESTS;

EID: 0032611195     PISSN: 00740276     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0074-02761999000100013     Document Type: Article

References (26)

1. Aikat BK, Pathania AGS, Sehgal S, Bhattacharya PK, Dutta U, Pasricha N, Singh S, Parman RS, Sahaya S, Prasad LSN 1979. Immunological responses in Indian kala-azar. Indian J Med Res 70: 583-591.
2. Barcellini W, Rizzardi GP, Borghi MO, Fain C, Lazzarin A, Meroni PL 1994. TH1 and TH2 cytokine production by peripheral blood mononuclear cells from HIV-infected patients. AIDS 8: 757-762.
3. Berens R, Marr J 1978. An easily prepared defined medium for cultivation of Leishmania donovani promastigotes. J Parasitol 64: 160-162.
4. Carvalho E, Bacellar O, Brownell C, Regis T, Coffman RL, Reed SG 1994. Restoration of IFN-γ production and lymphocyte proliferation in visceral leishmaniasis. J Immunol 152: 5949-5956.
5. Cenini P, Berhe N, Hailu A, McGinnes K, Frommel D 1993. Mononuclear cell subpopulations and cytokine levels in human visceral leishmaniasis before and after chemotherapy. J Infect Dis 168: 986-993.
6. Chomarat P, Rissoan M-C, Banchereau J, Miossec P 1993. Interferon-γ inhibits interleukin 10 production by monocytes. J Exp Med 177: 523-527.
7. Convit J, Castellanos P, Ulrich M, Castes M, Rondon A, Pinardi ME, Rodriguez N, Bloom BR, Formica S, Valecillos L, Bretana A 1989. Immunotherapy of localized, intermediate, and diffuse forms of American cutaneous leishmaniasis. J Infect Dis 160: 104-115.
8. Convit J, Rondon A, Ulrich M, Bloom B, Castellano PL, Pinardi M E, Castes M, Garcia L 1987. Immunotherapy versus chemotherapy in localized cutaneous leishmaniasis. Lancet I: 401-404.
9. Denis M, Ghadirian E 1994. Dysregulation of interleukin 8, interleukin 10, and interleukin 12 release by alveolar macrophages from HIV type 1 infected subjects. AIDS Res Hum Retroviruses 10: 1619-1627.
10. Dulley J, Grieve P 1975. A simple technique for eliminating interference by detergents in the Lowry method of protein determination. Anal Biochem 64: 136-141.
11. Evans T, Teixeira M, McAuliffe I, Vasconcelos I, Vasconcelos AW, Sousa AQ, Lima JW, Pearson RD 1992. Epidemiology of visceral leishmaniasis in northeast Brazil. J Infect Dis 166: 1124-1132.
12. Gajewski TF, Fitch FW 1988. Antiproliferative effect of IFN-γ in immune regulation I. IFN-γ inhibits proliferation of Th2 but not Th1 murine helper T lymphocyte clones. J Immunol 140: 4245.
13. Ghalib H, Piuvezam M, Skeiky Y 1993. Interleukin 10 production correlates with pathology in human Leishmania donovani infections. J Clin Invent 92: 324-329.
14. Ghalib H, Whittle JA, Kubin M, Hashim FA, El-Hassan AM, Grabstein KH, Trinchieri B, Reed SG 1995. IL-12 enhances Th1-type responses in human Leishmania donovani infections. J Immunol 154:4623-4629.
15. Ho M, Koech DK, Iha DW, Bryceson ADM 1983. Immunosuppression in Kenyan visceral leishmaniasis. Clin Exp Immunol 51: 207-214.
16. Holaday BH, Pompeu MM, Jeronimo S, Texeira MJ, Sousa AQ, Vasconcelos AW, Pearson RD, Abrams JS, Lockslcy RM 1993. Potential role for interleukin-10 in the immunosuppression associated with kala azar. J Clin Invest 92: 2626-2632.
17. Holaday BH, Pompeu MM, Evans T, Braga DN, Texeira MJ, Sousa AQ, Sadick MD, Vasconcelos AW, Abrams JS, Pearson RD, Locksley RM 1993. Correlates of Leishmania-spccific immunity in the clinical spectrum of infection with Leishmania chagasi. J Infec Dis 167: 411-417.
18. Hsieh C-S, Macatonia S, Tripp C, Wolf SF, O'Garra A, Murphy KM 1993. Development of Th1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 260: 547-549.
19. Karp CL, El-Safi SH, Wynn TA, Satti MMH, Kordofani AM, Hashim FA, Hag-Ali M, Neva FA, Nutman TB, Sacks DL 1993. In vivo cytokine profiles in patients with kala-azar: Marked elevation of both interleukin-10 and interferon-gamma. J Clin Invest 91: 1644-1648.
20. Maggi E, Giudizi MG, Biagiotti R, Annunziato F, Manetti R, Piccinni M-P, Parronchi P, Sampognaro S. Giannarini L, Zuccati G, Romagnani S 1994. Th2-like CD8+ T colls showing B cell helper function and reduced cytolytic activity in human immunodeficiency virus type 1 infection. J Exp Med 180: 489-495.
21. Manetti R, Parronchi P, Giudizi M, Piccinni M-P, Maggi E, Trinchieri G, Romagnani S 1993. Natural killer cell stimulatory factor [interleukin 12(IL-12)] induces T helper type 1 (Th1)-spccific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med 177: 1199-1204.
22. Salgame P, Abrams JS, Clayberger C, Goldstein H, Convit, J, Modlin RL, Bloom BR 1991. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science 254: 279-282.
23. Uyemura K, Pirmez C, Sieling P, Kiene K, Paes-Oliveira M, Modlin RL 1993. CD4+ type 1 and CD8+ type 2 T cell subsets in human leishmaniasis have distinct T cell receptor repertoires. J Immunol 151: 7095-7104.
24. Veress B, Omer A, Satir AA, El Hassan AM 1977. Morphology of the spleen and lymph nodes in fatal visceral leishmaniasis. Immunology 33: 605-609.
25. Yssel H, de Vries J, Koken M, Blitterswijk WV, Spits H 1984. Serum-free medium for generation and propagation of functional human cytotoxic and helper T cell clones. J Immunol Methods 72: 219-227.
26. Zwingenberger K, Harms G, Pedrosa C, Omena S, Sandkamp B, Neifer S 1990. Determinants of the immune response in visceral leishmaniasis: Evidence for predominance of endogenous interleukin 4 over interferon-γ production. Clin Immunol Immunopathol 57: 242-249.